Sign in Membership

Strategic Intelligence on China’s Health Policy, Coverage, and Financing System

Helping life sciences leaders navigate China’s health policy, coverage, and financing complexity for medical technologies — and translate system change into clearer access strategy and better-informed commercial decisions.

Published in Caixin and China Reform Magazine

Explore the 2026 Mid-Year Strategic Debrief

Engagement Paths

Access360

Access360 combines timely interpretation, synthesized strategic outlooks, and member Q&A to help life sciences leaders navigate China access decisions and pressure-test market assumptions across health policy, coverage, financing, and implementation uncertainty.

→ Explore Access360 Membership

China Access Outlook: Strategic Debrief

A mid-year and annual executive synthesis of major developments shaping China’s health policy, pricing, coverage, financing, and adoption environment for medical technologies — helping senior leaders understand what changed, why it matters, and what to watch next.

Available as on-demand executive briefings for standalone purchase or included with Access360 membership.

→ Explore the 2026 Mid-Year Strategic Debrief

NRDL+ Masterclass

Executive strategic foundation for China access decision-making.

Through structured interpretation and guided case application, participants connect system-level signals to strategic trade-offs and execution constraints in China’s evolving coverage landscape.

→ Explore NRDL+ Masterclass

Latest Access360 Briefings

Sep 17, 2026

China’s 15th Five-Year Medical Security Plan: Implications for Pharma and MedTech Strategy Through 2030

China has now set out its medical security priorities through 2030. This analysis looks beyond the policy language to examine what the emerging direction could mean for pharmaceutical and MedTech manufacturers planning for the Chinese market.
Sep 10, 2026

Press Release: NRDL+ Releases 2026 Mid-Year China Access Outlook as China Fine-Tunes Innovation Access Under Tighter Constraints

Executive strategic briefing examines how China’s evolving health policy, coverage, and financing environment is reshaping decisions across the medical technology lifecycle.
Aug 07, 2026

2026 Mid-Year China Access Outlook Strategic Debrief

Rebalancing Innovation Access Under Tighter Constraints As of mid-2026, recent and ongoing developments point to a more deliberate recalibration
Jun 17, 2026

China’s C-List and Beyond: Group Insurance, Provider Uptake, and Commercial Payment Strategies

A practical implementation deep-dive with Professor Wanyan on China’s C-List and broader commercial payment landscape — covering group health insurance, provider uptake, cross-stakeholder bottlenecks, orphan therapy coverage, TPAs, and scalable payment strategy.
Jun 10, 2026

China’s C-List in Practice: Early Huiminbao Integration Signals

A practical discussion with Professor Wanyan on Huiminbao benefit design changes, regional adoption differences, local negotiation dynamics, and what early implementation may signal for broader commercial insurance integration.
Jun 03, 2026

China’s C-List: Behind-the-Scenes Negotiation Dynamics

A practical implementation deep-dive into China’s 2025 C-List negotiation process with Professor Wanyan — covering insurer participation, NHSA’s role, selection criteria, pricing negotiation, and future commercial insurance formulary trends.